FIELD: chemistry.
SUBSTANCE: invention relates to novel benzyloxy-derivatives of general formula (I) 
, where R1 is a halogen; R2 is a 5-member heteroaryl group containing 2 or 3 heteroatoms selected from a group consisting of N, O or S, which can be substituted with R3, where R3 is a lower alkyl or -C(O)R; R is -NR'R" or lower alkoxy; R'/R" independently represent H; as well as to their pharmaceutically acceptable salts. Formula I compounds inhibit monoamine oxidase B.
EFFECT: compounds can be used for preparing a medicinal agent.
5 cl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF 4-PYRROLIDINE PHENYL BENZOLE ETHER | 2003 |
|
RU2336268C2 |
| DERIVATIVES OF PYRROLIDONE AS MONOAMINE OXIDASE B (MAO B) AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2003 |
|
RU2323209C2 |
| ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE | 2011 |
|
RU2611437C2 |
| OXAZOLIDINONE DERIVATIVES, METHOD FOR PREPARING THEREOF (VERSIONS) AND BASED PHARMACEUTICAL COMPOSITION | 2006 |
|
RU2417223C2 |
| PYRIDINEAMIDE DERIVATIVES AND MEDICINAL AGENT BASED ON THEREOF | 2003 |
|
RU2309950C2 |
| NOVEL PYRROLIDINE-3, 4-DICARBOXAMIDE DRIVATIVES | 2005 |
|
RU2379288C2 |
| DERIVATIVES OF 3-SUBSTITUTED 1,5-DIPHENYLPYRAZOLE EFFECTIVE AS CB1 MODULATORS | 2005 |
|
RU2375349C2 |
| DIPHENYL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF TREATMENT | 1997 |
|
RU2175319C2 |
| APPLICATION OF OXOZALIDINON-CHYNOLYN HYBRID ANTIBIOTICS FOR TREATMENT OF ANTHRAX AND OTHER INFECTIONS | 2004 |
|
RU2351335C2 |
| (3-CYCLOALKYL-2, 3, 4, 5 - TETRAHYDRO-1H-BENZO [d] AZEPIN-7-YLOXY) DERIVATIVES, USE THEREOF FOR INHIBITING H3 RECEPTORS, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD | 2003 |
|
RU2388752C2 |
